Evox Therapeutics logo

Evox Therapeutics

An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.

3

Funding Rounds

$143.4m

Money raised

Overview

An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.

Funding series

Funding Series Analysis

The company Evox Therapeutics has raised a total of $95.98m in funding over 3 rounds.

Key Insights:

  • Evox Therapeutics Series C round, February 19, 2021: $95.98m
  • Evox Therapeutics Ltd funding round, September 2018: $45.4m
  • Evox Therapeutics Ltd funding round, March 2019: $1.98m
Evox Therapeutics logo
Evox Therapeutics Series C round, February 19, 2021 $95.98m
Evox Therapeutics logo
Evox Therapeutics Ltd funding round, September 2018 $45.4m
Evox Therapeutics logo
Evox Therapeutics Ltd funding round, March 2019 $1.98m